• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.25% Nasdaq Up 0.65%

    Immune Pharmaceuticals, Inc. (IMNP)

    -NasdaqCM
    0.21 0.00(0.00%) May 27, 4:00PM EDT
    Prev Close:0.21
    Open:0.22
    Bid:0.20 x 1000
    Ask:0.23 x 1000
    1y Target Est:2.00
    Beta:1.67327
    Earnings Date:Aug 15 - Aug 19 (Est.)
    Day's Range:0.20 - 0.22
    52wk Range:0.20 - 2.23
    Volume:791,313
    Avg Vol (3m):258,586
    Market Cap:8.60M
    P/E (ttm):N/A
    EPS (ttm):-0.91
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for IMNP

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-16) :-0.52
    Quarterly EPS Est (Jun-16) :-0.13
    Mean Recommendation*:1.7
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Immune Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops and commercializes targeted therapeutics for the treatment of inflammatory diseases and cancer. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback